Medicine
Ferrlecit 62.5 mg/5 mL injection
Ferrlecit 62.5 mg/5 mL injection is a prescription medicine containing Sodium ferric gluconate complex for intravenous use, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20°C–25°C (68°F–77°F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Sodium ferric gluconate complex
- Brand
- Ferrlecit
- Strength
- 62.5 mg/5 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 vials of 5 mL
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturer
- Sanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20°C–25°C (68°F–77°F), excursions permitted to 15°C–30°C (59°F–86°F). See USP Controlled Room Temperature.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 March 2011
- Identifiers
- RxCUI 242761, 261123DailyMed set ID b25b34ab-9cf1-4a2b-bdf2-5eaf66625999, 1fe028ff-42ac-4329-b1a5-a9dadfcb79f6NDC 0024-2794, 0024-2792Application NDA020955
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 0024-2792-10 | sanofi-aventis | 1 March 2011 |
| 10 vial, single-use in 1 carton / 5 mL in 1 vial, single-use | 0024-2794-10 | sanofi-aventis | 7 July 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 February 1999 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sodium ferric gluconate complex 62.5 mg/5 mL injection.
Clinical summary
Sodium ferric gluconate complex is a parenteral iron replacement indicated for the treatment of iron deficiency anemia in adult patients, among other approved uses. MedsAcross supplies Sodium ferric gluconate complex for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium ferric gluconate complexFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Ferrlecit prescribing information (sanofi-aventis) · U.S. National Library of Medicine, DailyMed
Need Ferrlecit 62.5 mg/5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.